Cogent Biosciences

Cogent Biosciences is a biotechnology company focused on developing precision therapies for genetically defined diseases. With a commitment to advancing best-in-class small molecule therapeutics, Cogent aims to tackle diseases with clear genetic mutations as their cause. Their work is driven by a dedication to improve human health by designing rational precision therapies that address critical unmet medical needs. The company operates with a focus on diseases such as systemic mastocytosis, for which they are currently developing and advancing therapeutics like bezuclastinib. Cogent Biosciences highlights their commitment to transforming patient lives through innovative scientific approaches and robust clinical trials.